Pete Strothman
Managing Partner
Pete Strothman has spent his career investing in the healthcare industry. At Water Street, he has built a premier group of life science services and products companies. He also leads the firm's drug development initiatives, including establishing an innovative corporate partnership program that supports global organizations with developing next-generation pharmaceutical therapies and medical devices. Pete began his career in the Global Mergers and Acquisitions group of Lehman Brothers. He serves as a director of Allucent, Catalyx, EVERSANA, Discovery Life Sciences, Capstone Development Solutions, Long Grove Pharmaceuticals, MedSpeed, Solvias, Thread and Viant. Pete is a former director of AAIPharma Services, Bioclinica, Custopharm and OraPharma. He received a bachelor’s degree in economics from Harvard University.
Additional Investment Team Members
-
Mike Brennan -
Nicklaus Daley -
Tim Dugan -
Rob George -
Max Mishkin -
Katie Ossman -
Ryan Pavlik -
Christine Shtepani -
Patrick Teyro -
Ned Villers -
Rob Womsley -
Justuss Boice -
Paty Calderón -
Jeremy Champine -
Sam Franco -
Matt Knight -
Andy Lampereur -
Dan Malek -
Lucas Murphy -
Dan Pascetta -
Grace Rogers -
Hunter Schmidt -
Chris Sweeney